Wednesday, 01 December 2021


GenScript establishes Korean legal entity to accelerate commercialization

05 October 2021 | News

Aims to support R&D, importation, marketing, and distribution of reagent products and life science technology services in Korea

Photo Credit: Freepik

Photo Credit: Freepik

GenScript, a global biotech company, has established a legal entity "GenScript Biotech Korea Ltd." to strengthen its sales activities in Korea in earnest.

GenScript Biotech Korea Ltd. has built a nest at IKP (Invest Korea Plaza) in Heolleung-ro, Seocho-gu, Seoul.

The main purpose of the establishment of the company is to support Korean customers in the research and development, importation, marketing, and distribution of reagent products and life science technology service.

GenScript's business operations span over 100 countries and regions worldwide with legal entities located in the US, Mainland China, Hong Kong, Japan, Singapore, the Netherlands and Ireland. Through the development of various technologies, such as advances in cell therapy and creation of a customizable CRO solutions platform, GenScript has established itself as a global leader in biotechnology.

In 2019, the business field was expanded from the existing CRO business to biopharmaceutical CDMO services, through GenScript ProBio, which is establishing partnerships with a series of biotech companies in Korea.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account